Tobacco use and cancer: an epidemiologic perspective for geneticists

[1]  Richard Doll,et al.  The Mortality of Doctors in Relation to Their Smoking Habits , 1954, British medical journal.

[2]  G. Guindon,et al.  Tobacco control country profiles , 2003 .

[3]  J. Samet,et al.  Epidemiology of lung cancer. , 1994, Chest.

[4]  J. Minna,et al.  Focus on lung cancer. , 2002, Cancer cell.

[5]  E. Perez-stable,et al.  Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. , 2002, Journal of the National Cancer Institute.

[6]  T. Perneger.  Sex, smoking, and cancer: a reappraisal. , 2001, Journal of the National Cancer Institute.

[7]  R. Peto,et al.  Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998 , 2001, BMJ : British Medical Journal.

[8]  Elsie R. Pamuk,et al.  Health, United States, 2001; with Urban and rural health chartbook , 2001 .

[9]  Y. Nishino,et al.  Decrease in Risk of Lung Cancer Death in Males after Smoking Cessation by Age at Quitting: Findings from the JACC Study , 2001, Japanese journal of cancer research : Gann.

[10]  A. Olshan,et al.  GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. , 2001, American journal of epidemiology.

[11]  D. Sidransky,et al.  Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Stewart.  Lung carcinoma in African Americans , 2001, Cancer.

[13]  S R Tannenbaum,et al.  Gender- and smoking-related bladder cancer risk. , 2001, Journal of the National Cancer Institute.

[14]  Jack A. Taylor,et al.  DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[16]  K. Do,et al.  Smoking and prostate cancer. , 2001, Epidemiologic reviews.

[17]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[18]  S. Darby,et al.  N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene–environment interaction , 2000, British Journal of Cancer.

[19]  S. Hecht.  Metabolically activated carcinogens and mutations in the p53 tumor suppressor gene in lung cancer. , 2000, Journal of the National Cancer Institute.

[20]  J. Little,et al.  N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. , 2000, American journal of epidemiology.

[21]  A. Lindgren,et al.  The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia , 2000, International journal of cancer.

[22]  J. Califano,et al.  Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  S. Stellman,et al.  Doses of nicotine and lung carcinogens delivered to cigarette smokers. , 2000, Journal of the National Cancer Institute.

[24]  J. Luketich,et al.  Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. , 2000, Journal of the National Cancer Institute.

[25]  M. Corrao.  Tobacco control country profiles , 2000 .

[26]  H. Bartsch,et al.  Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  E. Bowman,et al.  Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. , 1999, Journal of the National Cancer Institute.

[28]  C. Weinberg,et al.  Gene-by-environment interaction for passive smoking and glutathione S-transferase M1? , 1999, Journal of the National Cancer Institute.

[29]  T. E. King,et al.  Racial disparity in rates of surgery for lung cancer. , 1999, The New England journal of medicine.

[30]  S S Smith,et al.  The epidemiology of tobacco use, dependence, and cessation in the United States. , 1999, Primary Care.

[31]  P. Vineis.  Metabolic Polymorphisms and Susceptibility to Cancer , 1999 .

[32]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[33]  J. Brown,et al.  Oral leukoplakia status six weeks after cessation of smokeless tobacco use. , 1999, Journal of the American Dental Association.

[34]  J. Califano,et al.  Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  J H Lubin,et al.  Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. , 1999, American journal of epidemiology.

[36]  G. Coetzee,et al.  Genetic variation of CYP2A6, smoking, and risk of cancer , 1999, The Lancet.

[37]  P. Sullivan,et al.  Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study , 1999, Molecular Psychiatry.

[38]  R. Peto,et al.  Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths , 1998, BMJ.

[39]  R. Peto,et al.  Emerging tobacco hazards in China: 2. Early mortality results from a prospective study , 1998, BMJ.

[40]  C. Rubin,et al.  Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions , 1998, Annals of Internal Medicine.

[41]  D. Sidransky,et al.  Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. , 1998, Journal of the National Cancer Institute.

[42]  M. Thun.  Mixed progress against lung cancer , 1998, Tobacco control.

[43]  E. Perez-stable,et al.  Nicotine metabolism and intake in black and white smokers. , 1998, JAMA.

[44]  E. Taioli,et al.  Lung cancer risk and CYP1A1 genotype in African Americans. , 1998, Carcinogenesis.

[45]  R Doll,et al.  Uncovering the effects of smoking: historical perspective , 1998, Statistical methods in medical research.

[46]  M. King,et al.  Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. , 1998, JAMA.

[47]  J. Thompson,et al.  BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. , 1998, JAMA.

[48]  N. Weiss,et al.  Menopausal hormone use and endometrial cancer, by tumor grade and invasion. , 1998, Epidemiology.

[49]  Nathaniel Rothman,et al.  Application of Biomarkers in Cancer Epidemiology , 1997 .

[50]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[51]  M. Thun,et al.  Cigarette smoking and changes in the histopathology of lung cancer. , 1997, Journal of the National Cancer Institute.

[52]  A. Neugut,et al.  Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  S. Hecht,et al.  Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  M. Gammon,et al.  Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. , 1997, Journal of the National Cancer Institute.

[55]  Rodolfo Saracci,et al.  Tobacco smoking and gastric cancer: Review and meta‐analysis , 1997, International journal of cancer.

[56]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[57]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[58]  S. Spivack,et al.  The molecular epidemiology of lung cancer. , 1997, Critical reviews in toxicology.

[59]  D. Wingard,et al.  Re: Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[60]  J. Freudenheim,et al.  Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.

[61]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[62]  T. Houston.  The Cigarette Papers , 1996 .

[63]  S. Lippman,et al.  Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.

[64]  S. Chapman.  The Cigarette Papers , 1996 .

[65]  J. Califano,et al.  11:40 AM: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996 .

[66]  F P Perera,et al.  Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. , 1996, Journal of the National Cancer Institute.

[67]  L. Kinlen.  Mortality from smoking in developed countries 1950-2000 , 1996, British Journal of Cancer.

[68]  R. Doll.  Cancers weakly related to smoking. , 1996, British medical bulletin.

[69]  J. Baron.  Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. , 1996, British Medical Bulletin.

[70]  L. Cardon,et al.  Behavior Genetic Approaches in Behavioral Medicine , 1995 .

[71]  A. Heath,et al.  Genetic Influences on Smoking Behavior , 1995 .

[72]  D. Phillips,et al.  Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. , 1994, Cancer research.

[73]  E. Taioli,et al.  A novel CYP1A1 gene polymorphism in African-Americans. , 1993, Carcinogenesis.

[74]  A. Miller,et al.  Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. , 1993, American journal of epidemiology.

[75]  R. Hoover,et al.  Lung cancer, race, and a CYP1A1 genetic polymorphism. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[76]  E. Wynder,et al.  Race and sex differences in lung cancer risk associated with cigarette smoking. , 1993, International journal of epidemiology.

[77]  H. Anton-Culver,et al.  Sex differences in lung‐cancer risk associated with cigarette smoking , 1993, International journal of cancer.

[78]  J. Idle,et al.  Metabolic polymorphisms. , 1993, Pharmacology & therapeutics.

[79]  J. Slade,et al.  Nicotine addiction : principles and management , 1993 .

[80]  E. Wynder,et al.  Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers , 1992, Cancer.

[81]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[82]  R C Brownson,et al.  Gender and histologic type variations in smoking-related risk of lung cancer. , 1992, Epidemiology.

[83]  J. Dosman,et al.  Men, women and primary lung cancer--a Saskatchewan personal interview study. , 1991, Journal of clinical epidemiology.

[84]  S H Moolgavkar,et al.  Two-event model for carcinogenesis: biological, mathematical, and statistical considerations. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[85]  R. Mulcahy.  The health benefits of smoking cessation. , 1990, Irish medical journal.

[86]  R. Heidel,et al.  Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. , 1989 .

[87]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .

[88]  P. Remington,et al.  Smoking by blacks and whites: socioeconomic and demographic differences. , 1988, American journal of public health.

[89]  M. Gaffney,et al.  Examination of the role of cigarette smoke in lung carcinogenesis using multistage models. , 1988, Journal of the National Cancer Institute.

[90]  J. Palca.  Nicotine addiction , 1988, Nature.

[91]  E. Pollack,et al.  What are the odds that smoking will kill you? , 1987, American journal of public health.

[92]  Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. , 1987, IARC monographs on the evaluation of carcinogenic risks to humans. Supplement.

[93]  J. Lilleyman.  Age-Related Factors in Carcinogenesis , 1986 .

[94]  J. Lubin,et al.  Assessment of lung cancer risk factors by histologic category. , 1984, Journal of the National Cancer Institute.

[95]  J. Harris.  SURVEY OF MECHANICAL WORKING PROCESSES , 1983 .

[96]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[97]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. , 1979, The New England journal of medicine.

[98]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.

[99]  N. Day,et al.  Incidence rates of specific histological types of lung cancer in Singapore Chinese dialect groups, and their aetiological significance , 1976, International journal of cancer.

[100]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.

[101]  J. Fraumeni,et al.  Cancer mortality among Chinese Americans, 1950-69. , 1974, Journal of the National Cancer Institute.

[102]  J. Clemmesen.  Statistical studies in the aetiology of malignant neoplasms. , 1974, Acta pathologica et microbiologica Scandinavica. Supplement.

[103]  E. C. Hammond,et al.  Histologic changes in the larynx in relation to smoking habits , 1970, Cancer.

[104]  E. C. Hammond,et al.  HISTOLOGIC CHANGES IN ESOPHAGUS IN RELATION TO SMOKING HABITS. , 1965, Archives of environmental health.

[105]  M. Pike,et al.  AGE AT ONSET OF LUNG CANCER: SIGNIFICANCE IN RELATION TO EFFECT OF SMOKING. , 1965, Lancet.

[106]  R. Doll,et al.  Mortality in Relation to Smoking: Ten Years' Observations of British Doctors , 1964, British medical journal.

[107]  Education Welfare.,et al.  Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .

[108]  K F WELLMANN,et al.  [SMOKING AND HEALTH. ON THE REPORT OF THE ADVISORY COMMITTEE TO THE SURGEON GENERAL OF THE PUBLIC HEALTH SERVICE]. , 1964, Deutsche medizinische Wochenschrift.

[109]  E. C. Hammond,et al.  Bronchial Epithelium in Former Smokers , 1962 .

[110]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. , 1961, The New England journal of medicine.

[111]  H. Dorn.  Tobacco consumption and mortality from cancer and other diseases. , 1959, Acta - Unio Internationalis Contra Cancrum.

[112]  E. C. Hammond,et al.  Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. , 1958, Journal of the American Medical Association.

[113]  Joseph Berkson,et al.  Smoking and Lung Cancer: Some Observations on Two Recent Reports , 1958 .

[114]  J. Engelbreth‐Holm,et al.  Production of carcinoma in ST/Eh mice with cigarette tar. , 2009, Acta pathologica et microbiologica Scandinavica.

[115]  M. Guérin,et al.  [Carcinogenic effects of coal tar from cigarette smoke on the skin of mice]. , 1957, Bulletin de l'Association francaise pour l'etude du cancer.

[116]  R. Doll,et al.  The Significance of Cell Type in Relation to the Aetiology of Lung Cancer , 1957, British Journal of Cancer.

[117]  R. Doll,et al.  Lung Cancer and Other Causes of Death in Relation to Smoking , 1956, British medical journal.

[118]  W. D. Stahlman.  Raymond Claire Archibald (1875-1955) , 1956, Isis.

[119]  W. Haenszel,et al.  Tobacco smoking patterns in the United States. , 1956, Public health monograph.

[120]  R. Doll,et al.  Smoking and Carcinoma of the Lung , 1950, Acta - Unio Internationalis Contra Cancrum.

[121]  M. Levin,et al.  Cancer and tobacco smoking; a preliminary report. , 1950, Journal of the American Medical Association.

[122]  E. A. Graham,et al.  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 1950, Journal of the American Medical Association.

[123]  L. Baker,et al.  Tobacco smoking as an etiologic factor in disease; cancer. , 1950, Cancer research.

[124]  A. Branch.  FACTORS IN CARCINOGENESIS. , 1939, Canadian Medical Association journal.